Revenues in the Diabetes group rose 12.6% organically to $647 million. U.S. revenues grew in the mid-teens on the continued adoption of the MiniMed 780G automated insulin delivery system.

The headline numbers from Medtronic highlight a solid start to its fiscal 2025. For the company's first quarter, adjusted ...

As chronic illnesses rise and technology leaps forward, the demand for cutting-edge medical devices intensifies. Medtronic ...

Pharmac – Te Pātaka Whaioranga has decided to fund continuous glucose monitors (CGMs), insulin pumps, and insulin pump consumables for people with type 1 diabetes from 1 October 2024.

Selbyville, Delaware, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Sensor Patch market is estimated to reach USD 60 billion by 2032, as ...

In April, Medtronic obtained FDA approval for another new product, Inceptiv, a spinal cord stimulator for treating chronic pain. The device can automatically adjust the therapy — a unique feature — to ...

Artificial intelligence has been the buzzword around Wall Street for many months but a recent selloff in the technology sector has ignited fears of an AI bubble.